Name | Title | Contact Details |
---|---|---|
Travis Pelfrey |
Director, Information Security Assurance | Profile |
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Next Breath is a Halethorpe, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Oxygen Plus Respiratory Care is a Vero Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Media Lab is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MyHealth Centre is a unique collaborative partnership of medical professionals and health care industry experts established in order to deliver quality and innovation in patient care. MyHealth Centre is a leading manager of independently owned diagnostic imaging facilities in Ontario. We currently manage over 25 Independent Health Facilities (IHFs) with agreements to develop additional IHF licenses.